In MCF-7 BC cells, RE was shown to increase chemosensitivity to the chemotherapy drug Adriamycin, promoting apoptosis by reducing the expression of cyclin-dependent kinases and Bcl-2. This evidence concerns the gene BCL2 and breast cancer.